Cavallaro Roberto Professore associatoMedicineMED/25 - Psichiatria
MD, Psichiatrist, is Associate Professor Of Psychiatry at the Faculty of Medicine and Surgery , Vita Salute San Raffaele University in Milan. He graduated with Summa cum Laude at the University of Milan Medical School in 1987 and specialized in Psychiatry with Summa cum Laude at the University of Milan Medical School in 1991 . His whole clinical, research and teaching career was developed at San Raffaele Universitary Scientific Institute Psychiatry Department and Vita Salute San Raffaele University in Milan.
His present clinical position is Director of the General Psychiatry acute and rehabilitation inpatient units and of the Psychotic Disorders Disease Unit at the San Raffaele Universitary Scientific Institute in San Raffaele Turro Hospital.
Since 2001 he teached in the faculties of Medicine and Surgery and Psychology, at Vita Salute San Raffaele University in Milan, with temporary positions of assistant professor in the Degree Courses of Psychological Sciences, Psychology and Medicine, in the Schools of Specialization of Psychiatry and Clinical Psychology and in the post-graduate Master in Clinical Psychopharmacology.
He is Director of the Master in Clinical Psychopharmacology at Vita Salute San Raffaele University in Milan and formerly was its clinical coordinator, since 2005 and Member of its Founding Commission since 2002.
He is author or co-author of more than 100 pubblications on international and national journals and books on topics of clinical psychiatry, neurobiology, clinical neuropsychology, neuropsychological rehabilitation, neuropsychiatry, clinical psychopharmacology, psychotropic drugs surveillance and pharmacokinetics. The main area of publication is that of schizophrenia and psychotic disorders and, in particular, more recently, that of the development of strategies for neurocognitive rehabilitation and of genetic control of cognitive performances in schizophrenia.
He organized several National and International meetings on topics of psychiatry and psychopharmacology. Since 2008 he is organizer and chairman of the ‘Cognition in schizophrenia satellite meeting’ of the biennial world congress of the Schizophrenia International Research Society.
He is member of the Editorial Board of the international journal ‘Schizophrenia Research: Cognition’ (Elsevier), and he was member of the Scientific Committee of Revision for the Italian edition of the DSM-V
He is member of the European College of Neuropsychopharmacology (ECNP) and ‘Fellow ’ for the same scientific society for the ‘ECNP certificate initiative’.
Selection of Representative Publications
Altamura AC, Mauri MC, Cavallaro R, A.Gorni. Haloperidol metabolism and antipsychotic effect in schizophrenia.The Lancet, (1987), I, 8536: 814-15.
Cavallaro R, Smeraldi E. A rare presentation of tardive dyskinesia American Journal of Psychiatry (1992), 149, 8:1115.
Cavallaro R, Regazzetti MG, Mundo E, Brancato V, Smeraldi E.. Tardive dyskinesia outcomes: Clinical and Pharmacological Correlates of Remission and Persistance. Neuropsychopharmacology (1993), 8 (3): 233-239.
Cavallaro R, Regazzetti MG, Covelli GP, Smeraldi E.. Tolerance and withdrawal with zolpidem. Lancet (1993), 342 (8867) 374-375.
Gambini O., Colombo C, Cavallaro R., Scarone S.. Smooth pursuit eye Movements and saccadic eye movements in patients with delusional disorder. Am J Psychiatry (1993), 150 (9):1411-1414.
Cavallaro R, Brambilla P, Smeraldi E. The sequential treatment approach to resistant schizophrenia with risperidone and clozapine: results of an open study with follow-up. Hum. Psychopharmacol Clin Exp (1998), 13 (2): 91-97.
Benedetti F, Cavallaro R, Smeraldi E. Olanzapine induced neutropenia after clozapine induced neutropenia Lancet (1999), 354 (9178) : 567
Cavallaro R, Mistretta P, Cocchi F, Manzato M, Smeraldi E. Differential efficacy of risperidone versus haloperidol in psychopathological subtypes of subchronic schizophrenia. Hum Psychopharmacol Clin Exp (2001), 16 (6): 439-42
Cavallaro R, Galardi G, Cavallini MC, Henin M, Amodio S, Bellodi L, Comi G. Obsessive compulsive disorder among idiopathic focal dystonia patients: An epidemiological and family study. Biological Psychiatry (2002), 52 (4): 356-361
Lerer B, Segman RH, Fangerau H, Daly AK; Basile VS, Cavallaro R, Aschauer HN, McCreadie RG, Ohlraun S, Ferrier N, Masellis M, Verga M, Scharfetter J, Rietschel M, Lovlie R, Levy UH, Meltzer HY, Kennedy JL, Steen VM, Macciardi F. Pharmacogenetics of tardive dyskinesia: Combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology (2002), 27( 1): 105-119
Cavallaro R, Cavedini P, Mistretta P, Bassi T, Angelone SM, Ubbiali A, Bellodi L. Basal Corticofrontal Circuits in Schizophrenia and Obsessive-Compulsive Disorder: A Controlled Double Dissociation Study . Biological Psychiatry (2003), 54 (4):437–443
Cavallaro R, Cocchi F, Angelone SM, Lattuada E, Smeraldi E. Cabergoline treatment of risperidone induced hyperprolactinaemia: a pilot study Journal of Clinical Psychiatry. (2004), 65(2):187-90
Pieroni M, Cavallaro R, Chimenti C, Smeraldi E, Frustaci A. Clozapine induced hypersensitivity Myocarditis. Chest, (2004), 126 (5):1703-5.
Lerer B, Segman RH, Tan E, Basile VS, Cavallaro R, Aschauer HN, Strous R, Chong SA, Heresco-Levy U, Verga M, Scharfetter J, Meltzer HY, Kennedy JL, Macciardi F. Combined analysis of 635 patients confirms an age-related association of the serotonin 2A receptor gene with tardive dyskinesia and specificity for the non-orofacial subtype. International Journal of Neuropsychopharmacology (2005) 8(3): 411-25.
Rossi A, Daneluzzo E, Tomassini A, Struglia F, Cavallaro R, Smeraldi E, Stratta P. The effect of verbalization strategy on Wisconsin Card Sorting Test performance in schizophrenic patients receiving classical or atypical antipsychotics. BMC Psychiatry. (2006), 6: 3.
van Os J, Burns T, Cavallaro R, Leucht S, Peuskens J, Helldin L, Bernardo M, Arango C, Fleischhacker W, Lachaux B, Kane JM . Standardised remission criteria in schizophrenia Acta Psychiatrica Scandinavica (2006), 113 (2): 91-5.
Anselmetti S, Cavallaro R, Bechi M, Angelone SM, Ermoli E, Cocchi F, Smeraldi E Psychopathological and neuropsychological correlates of source monitoring impairment in schizophrenia. Psychiatry Research (2007), 150 (1): 51-59.
Bosia M, Bechi M, Marino E, Anselmetti S, Poletti S, Cocchi F, Smeraldi E, Cavallaro R. Influence of Catechol-O-Methyltrasferase Val158Met polymorphism on neuropsychological and functional outcomes of classical rehabilitation and cognitive remediation in schizophrenia . Neuroscience Letters (2007) 417 (3): 271-247
Spina E, Cavallaro R. The safety of paliperidone extended-release in the treatment of schizophrenia. Expert Opinion on Drug Safety (2007), 6 (6):651-62. ISSN: 1474-0338
Anselmetti S, Poletti S, Ermoli E, Bechi M, Cappa S, Venneri A, Smeraldi E, Cavallaro R. The Brief Assessment of Cognition in Schizophrenia. Normative data for the Italian population. Neurological Sciences. (2008), 29(2):85-92
Anselmetti S, Bechi M, Bosia M, Quarticelli C, Ermoli E, Smeraldi E, Cavallaro R. ‘Theory’ of mind impairment in patients affected by schizophrenia and in their parents. Schizophrenia Research (2009),115 (2): 278-85.
Cavallaro R, Anselmetti S, Poletti S, Bechi M, Ermoli E, Cocchi F, Stratta P, Vita A, Rossi A, Smeraldi E. Computer-aided neurocognitive remediation as an enhancing strategy for schizophrenia rehabilitation. Psychiatry Research (2009), 169(3):191-6.
Benedetti F, Bernasconi A, Bosia M, Cavallaro R, Dallaspezia S, Falini A, Poletti S, Radaelli D, Riccaboni R, Scotti G, Smeraldi E. Functional and structural brain correlates of theory of mind and empathy deficits in schizophrenia. Schizophrenia Research (2009), 114 (1) :154-60.
Bosia M, Anselmetti S, Pirovano A, Ermoli E, Marino E, Bramanti P, Smeraldi E, Cavallaro R. HTTLPR functional polymorphism in schizophrenia: executive functions vs. sustained attention dissociation. Prog Neuropsychopharmacol Biol Psychiatry. (2010); 34 (1): 81-5. 49) Schettino A, Lauro LR, Crippa F,
Anselmetti S, Cavallaro R, Papagno C. The comprehension of idiomatic expressions in schizophrenic patients. Neuropsychologia. (2010), 48 (4): 1032-40.
Poletti, S., Anselmetti, S., Bechi, M., Ermoli, E., Bosia, M., Smeraldi, E., Cavallaro, R.Computer-aided neurocognitive remediation in schizophrenia: Durability of rehabilitation outcomes in a follow-up study Neuropsychological Rehabilitation (2010), 20 (5):659-674
Bosia, M., Anselmetti, S., Bechi, M., Lorenzi, C., Pirovano, A., Cocchi, F., Buonocore, M., Bramanti, P., Smeraldi, E., Cavallaro, R. Effect of 5-HT1A-receptor functional polymorphism on Theory of Mind performances in schizophrenia Psychiatry Research (2011), 188 (2): 187-90.
Rabinowitz, J., Napryeyenko, O., Burba, B., Martinez, G., Neznanov, N.G., Fischel, T., Baylé, F.J., Cavallaro, R., Smeraldi, E., Schreiner, A. Premorbid functioning and treatment response in recent-onset schizophrenia: Prospective study with risperidone long-acting injectable Journal of Clinical Psychopharmacology (2011), 31 (1): 75-81.
Spangaro M, Bosia M, Zanoletti A, Bechi M, Cocchi F, Pirovano A, Lorenzi C, Bramanti P, Benedetti F, Smeraldi E, Cavallaro R. Cognitive dysfunction and glutamate reuptake: Effect of EAAT2 polymorphism in schizophrenia. Neuroscience Letters. (2012), 522(2):151-5.
Llorca PM, Blanc O, Samalin L, Bosia M, Cavallaro R. Factors involved in the level of functioning of patients with schizophrenia according to latent variable modeling. European Psychiatry. (2012), 27 (6): 396-400
Poletti S, Anselmetti S, Riccaboni R, Bosia M, Buonocore M, Smeraldi E, Cavallaro R. Self awareness of cognitive functioning in schizophrenia: patients and their relatives. Psychiatry Research.(2012), 198(2): 207-11
Riccaboni R, Fresi F, Bosia M, Buonocore M, Leiba N, Smeraldi E, Cavallaro R. Patterns ofevidence integration in schizophrenia and delusion. Psychiatry Research. (2012), 200 (2): 108-14
Bechi M, Riccaboni R, Ali S, Fresi F, Buonocore M, Bosia M, Cocchi F, Smeraldi E, Cavallaro R. Theory of mind and emotion processing training for patients with schizophrenia: preliminary findings. Psychiatry Research (2012), 198 (3): 371-7
Bechi M, Spangaro M, Bosia M, Zanoletti A, Fresi F, Buonocore M, Cocchi F, Guglielmino C,Smeraldi E, Cavallaro R. Theory of Mind intervention for outpatients with schizophrenia. Neuropsychological Rehabilitation. (2013), 23 (3): 383-400
Poletti S, Radaelli D, Bosia M, Buonocore M, Pirovano A, Lorenzi C, Cavallaro R, Smeraldi E, Benedetti F. Effect of glutamate transporter EAAT2 gene variants and gray matter deficits on working memory in schizophrenia. European Psychiatry. (2014), 29 (4): 219-25
Bosia M, Zanoletti A, Spangaro M, Buonocore M, Bechi M, Cocchi F, Pirovano A, Lorenzi C, Bramanti P, Smeraldi E, Cavallaro R. Factors affecting cognitive remediation response in schizophrenia: The role of COMT gene and antipsychotic treatment. Psychiatry Research, (2014), 217(1): 9-14
Spangaro M, Bosia M, Zanoletti A, Bechi M, Buonocore M, Pirovano A, Lorenzi C, Bramanti P, Smeraldi E and Cavallaro R Exploring effects of EAATs polymorphisms on cognitive functions in schizophrenia. Pharmacogenomics (2014), 15 (7): 925-32.
Pinna F, Bosia M, Cavallaro R, Carpiniello B. Consensus five factor PANSS for evaluation of clinical remission: effects on functioning and cognitive performances. Schizophrenia Research: Cognition (2014), 1:187-192
Bosia M, Pigoni A, Cavallaro R. Genomics and Epigenomics in novel schizophrenia drug discovery: translating animal models to clinical research and back. Expert Opinion in Drugs Discovery (2015), 10 (2): 125-139.
Bosia M, Lorenzi C, Pirovano A, Guglielmino C, Cocchi F, Spangaro M, Bramanti P, Smeraldi E, Cavallaro R. COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine. Pharmacogenomics (2015), 16(1): 35-44
Buonocore MC, Bosia M, Riccaboni R, Bechi M, SpangaroM, Piantanida M, Cocchi F, Guglielmino C, Bianchi L, Smeraldi E, Cavallaro R. Combined neurocognitive and metacognitive rehabilitation in schizophrenia: effects on bias against disconfirmatory evidence. European Psychiatry (2015), 30(5):615-21.
Bechi M, Bosia M, Spangaro M, Buonocore M, Cocchi F, Pigoni A, Piantanida M, Guglielmino C, Bianchi L, Smeraldi E and Cavallaro R. Combined social cognitive and neurocognitive rehabilitation strategies in schizophrenia: neuropsychological and psychopathological influences on Theory of Mind improvement. Psychological Medicine (2015), 45(15): 3147-57 .
Moro A, Bambini V, Bosia M, Anselmetti S, Riccaboni R, Cappa SF, Smeraldi E,Cavallaro R. Detecting syntactic and semantic anomalies in schizophrenia. Neuropsychologia. (2015), 79 (PtA): 147-157
Bosia M, Pigoni A, Zagato L, Merlino L, Casamassima N, Lorenzi C, Pirovano A, Smeraldi E, Manunta P, Cavallaro R. ADDing a piece to the puzzle of cognition in schizophrenia. Eur J Med Genet. (2016) 59(1):26-31
Poletti S, Mazza E, Bollettini I, Falini A, Smeraldi E, Cavallaro R, Benedetti F. The COMT Val158Met polymorphism moderates the association between cognitive functions and white matter microstructure in schizophrenia. Psychiatr Genet. (2016) 26(5):193-202
Bambini V, Arcara G, Bechi M, Buonocore M, Cavallaro R, Bosia M. The communicative impairment as a core feature of schizophrenia: Frequency of pragmatic deficit, cognitive substrates, and relation with quality of life. Compr Psychiatry. (2016) 26;71:106-120
Cognitive remediation and functional improvement in schizophrenia: Is it a matter of size? Bosia M, Buonocore M, Bechi M, Spangaro M, Pigoni A, Croci M, Cocchi F, Guglielmino C, Bianchi L, Smeraldi E, Cavallaro R. (2017) European Psychiatry, 40: 26-32
Il titolare del presente curriculum vitae, pubblicato online sul portale www.unisr.it, è garante in via esclusiva della correttezza e della veridicità dei dati e delle informazioni in esso riportate e del loro eventuale e puntuale aggiornamento. Egli è dunque il diretto ed unico responsabile dei contenuti indicati nei propri curricula.